New drug hopes to get seniors moving again
NCT ID NCT05727384
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This study tests whether a drug called Clazakizumab can improve walking speed and reduce disability in older adults with chronic inflammation. About 29 people aged 70 and older will receive either the drug or a placebo every 4 weeks for 24 weeks. Researchers will measure walking speed, blood markers, and physical and mental function to see if the treatment helps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pittsburgh, Health Studies Research Center
Pittsburgh, Pennsylvania, 15260, United States
Conditions
Explore the condition pages connected to this study.